Tag archive for ‘Biotech’

7 Israeli robots that are transforming surgery

#ViRob Robotic or robot-assisted surgery can give doctors better vision, precision, flexibility and control when performing complex minimally invasive procedures. Someday, surgeons will even use More...

News Brief On Wednesday, May 4th, 2016

Dead could be brought ‘back to life’ in groundbreaking project

A biotech company is seeking 20 people who have been declared clinically dead for an attempt to reawaken parts of their central nervous systems. Philadelphia-based Bioquark, Inc. has been granted ethical approval More...

Gil Tanenbaum On Tuesday, February 9th, 2016

Check Out The New Optic Tech Being Developed in Israel

 3Dot The 2016 Business Opportunities in Israel Lasers Electro-Optics conference was held at the Lev Academic Center in Jerusalem last week. A number of startups which use new technologies were represented More...

Jewish Business News On Tuesday, November 3rd, 2015

How much does it hurt? New system quantifies pain at last

  Rate your pain on a scale of 1 to 10: Health professionals rely on this subjective method to assess pain. It’s not only imprecise but also impossible in many circumstances, such as when the patient More...

Eli Horn On Monday, December 29th, 2014

Biotech Company Juno Therapeutics Possibly on George Soros’ Radar

Billionaire investor George Soros may have an interest in Juno Therapeutics, an immunotherapy stock that had its IPO last Friday, multimedia financial services company The Motley Fool said. As of the end More...

Vered Weiss On Wednesday, December 24th, 2014

Why Jim Cramer Is Staying Away from Biotechs

Jim Cramer on his CNBC Mad Money program was bullish on biotechs all summer. This was after a surplus of biotech IPOs flooded the market in the spring, and the sector bottomed. Biotechs rebounded with a vengeance More...

Vered Weiss On Monday, December 15th, 2014

George Soros Dumps Biotech

–   The biotech sector has been outperforming the S&P 500, and some money managers continue to buy even as others are concerned about a bubble, as reported by Motley Fool.     The iShares  More...

Reuters On Thursday, November 27th, 2014

Exclusive: First gene therapy drug sets million-euro price record

–     The Western world’s first gene therapy drug is set to go on sale in Germany with a 1.1 million euro ($1.4 million) price tag, a new record for a medicine to treat a rare disease. The More...

Vered Weiss On Wednesday, November 12th, 2014

Jim Cramer: Biotech, Housing and Cult Stocks Driving Market

On his Tuesday, November 11th episode of Mad Money on CNBC, Cramer identified 3 sectors that are leading stocks: Biotech, Housing and “Cult Stocks.” Regeneron was the surprise driver of biotech. More...

Gil Tanenbaum On Monday, October 27th, 2014

Clal Biotech Sells Pidilizumab Cancer Treatment Rights to Medivation

Israel’s Clal Biotechnology Industries has sold the exclusive worldwide commercialization rights for its cancer treatment pidilizumab to the American company Medivation. The rights are held by Clal subsidiary More...

Wordpress site Developed by Fixing WordPress Problems